Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Tissue plasminogen activator gene expression in multiple sclerosis brain tissue.

F O Akenami1, V Sirén, M Wessman

  • 1Haartman Institute, Department of Virology, University of Helsinki, Finland. francis.akenami@helsinki.fi

Journal of the Neurological Sciences
|July 30, 1999
PubMed
Summary

Tissue-type plasminogen activator (tPA) is highly expressed in multiple sclerosis (MS) brain neurons, suggesting its role in demyelination. Targeting tPA or plasmin may offer new therapeutic strategies for MS.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Epidemiology of Sindbis virus infections in Finland 1981-96: possible factors explaining a peculiar disease pattern.

Epidemiology and infection·2002
Same author

Tissue plasminogen activator as a key effector in neurobiology and neuropathology.

Biochemical Society transactions·2002
Same author

Antibody status to HHV-6 in children with leukaemia.

Leukemia·2002
Same author

Mapping of B-cell epitopes in the nucleocapsid protein of Puumala hantavirus.

Viral immunology·2002
Same author

[Gene amplification methods in viral diagnostics].

Duodecim; laaketieteellinen aikakauskirja·2002
Same author

Chlamydia trachomatis infection in mothers with preterm delivery and in their newborn infants.

APMIS : acta pathologica, microbiologica, et immunologica Scandinavica·2002

Area of Science:

  • Neuroscience
  • Immunology
  • Pathology

Background:

  • Multiple sclerosis (MS) is a central nervous system demyelinating disease.
  • Neurodegeneration in MS has been linked to tissue-type plasminogen activator (tPA).

Observation:

  • tPA gene and protein expression were analyzed in MS and reference brain tissues using in situ hybridization and immunohistochemistry.
  • MS brain neurons exhibited high tPA mRNA and protein levels.
  • Reference brains showed minimal neuronal tPA expression, primarily in blood vessels.

Findings:

  • Significant tPA expression was observed in neuronal cell bodies within MS brain tissue.
  • Additional tPA staining was detected in mononuclear cells and foamy macrophages in MS lesions.
  • In contrast, reference brain neurons had very low tPA expression, mainly localized to blood vessel walls.

Related Experiment Videos

Implications:

  • The findings suggest tPA, and by inference plasmin, are involved in the enzyme-mediated demyelination process in MS.
  • Blocking tPA or plasmin activity could represent a novel therapeutic avenue for managing MS.
  • This research highlights potential molecular targets for future MS treatments.